2023
Year In Review
In 2023 we celebrated 7 years of successful business
Our working community increased to 600+ employees
Two offices were opened, giving SmithRx four in-person locations
Our teams were enhanced. One of which being the Member Support team that grew by 200%
New Member Portal tools were launched like Find My Meds and Member chat
We added new and improved Connect 360 Programs, including:
Low Cost Insulin
Humira Biosimilars
Diabetes Non-Insulin
We achieved over 500k Members under management
SmithRx grew its employer base to 3,500+ clients
We saved our employer groups over $200M delivered from Connect 360 programs
Our data integrations expanded to include 100+ TPA integrations
We're consistently saving employers 20% or more of their total drug costs compared to legacy PBMs
We began two new partnerships this year including Mark Cuban Cost Plus Drugs and Amazon Pharmacy
And finally, with our average member satisfaction at 4.3 stars on Google Reviews, SmithRx is leading the PBM industry with excellent customer care.
That’s a wrap! Thank you for an incredible year.
We look forward to working with you in 2024 and beyond.
See more of our 2023 Year in Review